Saturday, June 22, 2024

Don't Miss

AbbVie’s Skyrizi Secures Key FDA Approval

AbbVie's Skyrizi secures FDA approval for ulcerative colitis, expanding its reach and reinforcing its position in the bowel disease market.

LATEST ARTICLES

Most Popular

Recent Comments